Canos develops blood-based genomic testing for dogs, offering multi-cancer screening, cancer monitoring and relapse tracking, and genetic and epigenetic health baselines
Canos develops blood-based genomic testing for dogs, offering multi-cancer screening, cancer monitoring and relapse tracking, and genetic and epigenetic health baselines. Its liquid biopsy tests use cell-free DNA and are delivered with veterinary visits and report review with the pet’s veterinarian.